{
  "nctId": "NCT02590939",
  "briefTitle": "Acute Treatment of Migraine With e-TNS",
  "officialTitle": "Multi-center, Double-blind, Randomized, Sham-controlled Trial on the Acute Treatment of Migraine With the Cefaly® Device",
  "protocolDocument": {
    "nctId": "NCT02590939",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2016-07-11",
    "uploadDate": "2018-02-07T10:14",
    "size": 1276510,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02590939/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "TRIPLE",
  "enrollmentInfo": {
    "enrollmentCount": 106,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2016-02-01",
    "completionDate": "2017-03-31",
    "primaryCompletionDate": "2017-03-31",
    "firstSubmitDate": "2015-10-28",
    "firstPostDate": "2015-10-29"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* History of episodic or chronic migraine with or without aura meeting the diagnostic criteria listed in ICHD-III beta (2013) section 1, migraine, with the exception of ''complicated migraine'' (i.e., hemiplegic migraine, basilar-type migraine, ophthalmoplegic migraine, migrainous infarction)\n* Having a migraine attack lasting at least 3 hours\n* Migraine pain intensity stabilized for at least 1 hour\n* Frontal, retro-, or peri- orbital headache.\n\nExclusion Criteria:\n\n* Pregnant women\n* Patients having received Botox treatment in the prior 4 months\n* Patients having received supraorbital nerve blocks in the prior 4 months\n* Diagnosis of other primary or secondary headache disorders, except of Medication Overuse Headache\n* Patients with only temporal or occipital headache\n* Patients using opioid medication\n* Patients having taken abortive migraine medication in the prior 3 hours\n* Allodynia: intolerance to supraorbital neurostimulation (allodynia) that makes the treatment not applicable (the patients will be excluded if they are unable to tolerate the first 5 minutes of neurostimulation).\n* Implanted metal or electrical devices in the head\n* Cardiac pacemaker or implanted or wearable defibrillator\n* Patient having had a previous experience with Cefaly®",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "65 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Pain Score 1-hour",
        "description": "Mean change of pain score (measured on a pain visual analog scale containing 11 values, from 0 to 10, with 0 meaning no pain and 10 meaning maximal pain) at 1 hour compared to baseline",
        "timeFrame": "1 hour"
      }
    ],
    "secondary": [
      {
        "measure": "Rescue Medication 2 Hours",
        "description": "Number of patients not having required rescue medication at 2 hours",
        "timeFrame": "2 hours"
      },
      {
        "measure": "Pain Score 2 Hours",
        "description": "Mean change of pain score (measured on a pain visual analog scale containing 11 values, from 0 to 10, with 0 meaning no pain and 10 meaning maximal pain) at 2 hours compared to baseline (if rescue therapy was not used)",
        "timeFrame": "2 hours"
      },
      {
        "measure": "Rescue Medication 24 Hours",
        "description": "Number of patients not having required rescue medication within 24 hours",
        "timeFrame": "24 hours"
      },
      {
        "measure": "Pain Score 24 Hours",
        "description": "Mean change of pain score (measured on a pain visual analog scale containing 11 values, from 0 to 10, with 0 meaning no pain and 10 meaning maximal pain) at 24 hours compared to baseline (if rescue therapy was not used)",
        "timeFrame": "24 hours"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 4,
      "otherCount": 0,
      "totalCount": 5
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 59,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:29:54.409Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}